Chronic prostatitis
Conditions
Interventions
experimental group:Dan Yi Tablet
Control group:Placebo
Sponsors
Second affiliated Hospital of Tianjin University of TCM
Eligibility
Sex/Gender
Male
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: 1. in line with western medicine of chronic prostatitis diagnosis standard; 2. with TCM Syndromes of blood stasis of damp-heat in diagnostic criteria; 3. age 18-50 years old, male; 4. more than 3 months duration; 5. trials within 2 weeks before receiving the same medication or other treatment; 6. signed informed consent.
Exclusion criteria
Exclusion criteria: 1. acute prostatitis; 2. benign prostatic hyperplasia, prostate cancer, neurogenic bladder, urethritis, urethral malformation or stenosis and severe neurosis; 3. to local pain as the main manifestations of the patients, attention should be paid to exclude the lower abdomen, perineum, lumbosacral and other parts of the other lesions, such as ureteral calculus, vesical calculus, inguinal hernia, osteitis pubis, varicocele, epididymitis, rectosigmoid colon diseases, such as lumbar back myofascitis; 4. combine heart, brain, liver and kidney and hematopoietic system of severe primary diseases; 5. allergic or to test drug ingredients known allergy; 6. active ulceration and bleeding tendency; 7. cannot be partners, such as psychiatric patients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| NIH-CPSI score (total score, pain score, QOL score);TCM syptom total score; | — |
Secondary
| Measure | Time frame |
|---|---|
| EPS examination;prostate digital examination;Prostatic fluid bacterial culture;The single symptom scores; | — |
Countries
China
Contacts
Public ContactWei Rui
Outcome results
None listed